In fact, serum expression of endocan could discriminated bladder cancer patients with a sensitivity of 50% and specificity of 77% while the urinary endocan expression resulted in a sensitivity of 62% and specificity of 71% [240]. Here, ESM1 is linked to urinary bladder carcinoma.